Streetbeat News

Stock Prices

NOC

Northrop Grumman reports progress in the B-21 Raider program, highlighting advancements in the flight test campaign and scaling into production.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 9:18 pm

BTCUSD

DOGEUSD

ETHUSD

Cryptocurrency markets are stabilizing after the Federal Reserve's 50-basis-point interest rate cut, making risk assets more appealing. Bitcoin, Ethereum, and Dogecoin are among the cryptocurrencies reacting to this decision. Notably, U.S. Bitcoin ETFs are purchasing more Bitcoin than is being mined, indicating strong institutional interest.

Portfolio Pulse from Khyathi Dalal

September 18, 2024 | 9:12 pm

SANG

Sangoma Technologies reported a Q4 2024 GAAP EPS of $(0.05), missing the $(0.03) estimate, and sales of $60.93M, slightly below the $61.03M estimate. This represents a 4.31% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 9:10 pm

ALGS

Aligos Therapeutics is set to release topline results from its Phase 2a HERALD study of ALG-055009, targeting metabolic-dysfunction associated steatohepatitis (MASH). This development could impact the company's stock performance.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 9:03 pm

TGTX

TG Therapeutics (NASDAQ:TGTX) has received diverse evaluations from analysts, with a majority being bullish. The average 12-month price target has increased to $38.0. The company shows strong financial performance with significant revenue growth and profitability, but faces challenges in debt management.

Portfolio Pulse from Benzinga Insights

September 18, 2024 | 9:01 pm

CORT

Corcept Therapeutics (NASDAQ:CORT) has received varied analyst ratings over the past three months, with a trend towards more bullish sentiments. Analysts have raised their 12-month price targets, with an average target of $50.17, reflecting a 34.4% increase from the previous average. The company's strong revenue growth and efficient cost management are highlighted, although its return on equity is below industry averages.

Portfolio Pulse from Benzinga Insights

September 18, 2024 | 9:01 pm

PYPL

Analysts have varied opinions on PayPal Holdings (NASDAQ:PYPL), with recent ratings showing a mix of bullish and indifferent sentiments. The average 12-month price target has increased to $78.62. PayPal's financial performance shows revenue growth but challenges in profitability and returns.

Portfolio Pulse from Benzinga Insights

September 18, 2024 | 9:00 pm

WH

Analysts have provided mixed ratings for Wyndham Hotels & Resorts (NYSE:WH) over the past three months, with a majority being bullish. The average 12-month price target is $91.8, slightly down from previous estimates. The company's financials show strong profitability but challenges in debt management.

Portfolio Pulse from Benzinga Insights

September 18, 2024 | 9:00 pm

SCS

Steelcase Inc. (NYSE:SCS) shares fell after reporting Q2 earnings that beat expectations but missed on revenue. The company saw growth in the Americas but faced international challenges, particularly in China. Steelcase projects Q3 revenue between $785M and $810M.

Portfolio Pulse from Erica Kollmann

September 18, 2024 | 8:56 pm

XCUR

Exicure Inc (NASDAQ:XCUR) shares soared in after-hours trading following an announcement of a Nasdaq listing extension. The company must comply with listing criteria by Nov. 14. Exicure recently regained compliance with Nasdaq's minimum bid price and converted $1 million of debt to equity. The stock, a low-float micro-cap, more than doubled, reaching new 52-week highs.

Portfolio Pulse from Adam Eckert

September 18, 2024 | 8:51 pm